Evidence map›Paper›PMID 24306515›Full record

ArticleFamilial cancer2014

Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing.

Ian Teng, Allan Spigelman

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.The British journal of general practice : the journal of the Royal College of General Practitioners · 2019
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Clinical cancer genomic profiling.Nature reviews. Genetics · 2021
    Review
  9. Article
  10. Integrating Germline Genetics Into Precision Oncology Practice in the Veterans Health Administration: Challenges and Opportunities.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020
    Article
  11. Observational
  12. Article
  13. The value of genetic testing: beyond clinical utility.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  14. Article
  15. Article
  16. The financial hazard of personalized medicine and supportive care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Article
  17. Genetics educational needs in China: physicians' experience and knowledge of genetic testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2015
    Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ian TengUniversity of New South Wales, Unit 3, 39-41 Houston Road, Kingsford, NSW, 2032, Australia, iantengwy9114@hotmail.com.
Allan Spigelman
St Vincent's Clinic · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic testing for susceptibility for common cancers is widely available. Thus, doctors have a role in identifying and referring patients who would benefit from a consultation with a specialist in genetics. This study aims to assess doctors' referral rates, knowledge and attitudes towards cancer genetic testing, broken down by specialty (gastrointestinal, breast/ovarian, other specialties and General Practitioners-GPs). A 4-page questionnaire was mailed out to the GPs of all patients seen in 2012 in the Hereditary Cancer Clinic of St. Vincent's Hospital Sydney (n = 128) and all the specialists in St. Vincent's Hospital Sydney that might refer to the HCC (n = 33). 50 questionnaires were returned (31 %). Most doctors had referred a patient for cancer genetic testing (90 %). The average proportion of patients referred was 1 in 68.5 patients with breast/ovarian specialists referring the most, followed by gastrointestinal specialists and GPs. There was suboptimal knowledge of cancer genetic testing amongst doctors. Breast/ovarian specialists were most knowledgeable, followed by gastrointestinal specialists, other specialists and GPs. There were indications of inappropriate referral amongst doctors. Most (77.6 %) doctors were willing to receive further information on cancer genetics. Nearly all (94 %) doctors believe that it is their duty to inform an individual at high risk for hereditary cancer that cancer genetic counselling and testing is available. The majority of doctors have positive attitudes towards cancer genetic testing. Defective knowledge scores, however, indicate that doctors need further training or tools to enable them to refer patients appropriately for cancer genetic testing.

Indexed as

Attitude of Health PersonnelHealth Knowledge, Attitudes, PracticeGastroenterologyGeneral PracticeGenetic TestingGynecologyHumansNeoplastic Syndromes, HereditaryPatient Education as TopicReferral and ConsultationSurveys and Questionnaires

Identifiers

PMID24306515
OpenAlexW2014042380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.